➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: September 23, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for Mannose

Email this page to a colleague

« Back to Dashboard

What is the drug development status for Mannose?

Mannose is an investigational drug.

There have been 28 clinical trials for Mannose. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2019.

The most common disease conditions in clinical trials are Infection, Urinary Tract Infections, and Communicable Diseases. The leading clinical trial sponsors are Renovo, Shire, and Enzon Pharmaceuticals, Inc.

Recent Clinical Trials for Mannose
Phase II Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions and Cardiovascular Atherosclerosis.Universitair Ziekenhuis BrusselPhase 2
Feasibility of IV Tc-99m-tilmanocept for Imaging of M2-like TAMs in Metastatic MelanomaJohn O. PriorEarly Phase 1
Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)Johns Hopkins UniversityPhase 2

See all Mannose clinical trials

Clinical Trial Summary for Mannose

Top disease conditions for Mannose
Top clinical trial sponsors for Mannose

See all Mannose clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.